Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Spinal Magnetic Stimulation in Neuropathic Pain
This study is currently recruiting participants.
Verified by Singapore General Hospital, March 2007
Sponsored by: Singapore General Hospital
Information provided by: Singapore General Hospital
ClinicalTrials.gov Identifier: NCT00443469
  Purpose

It involves delivering a train of magnetic pulses, 5 at each time, to the brain. In the present study, we are using the same method to treat severe pain due to nerve conditions. You will be given up to 1000 pulses in total over the spine in the lower back (Spinal Magnetic Stimulation or SMS). Each train will be given in 10-second intervals. You will have SMS on a single day. You will be given SMS pulses at 1 or 10 per second. No stimulation will be given over the head.

You will be assessed before and after the study for up to 1 week. Your usual medical treatment will be continued


Condition Intervention Phase
Neuropathic Pain
Device: magnetic stimulation
Phase III

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study
Official Title: A Randomized Placebo-Controlled Trial on the Use of Repetitive Spinal Magnetic Stimulation as a Therapeutic Option in Patients With Intractable Neuropathic Pain of the Lower Limbs

Further study details as provided by Singapore General Hospital:

Primary Outcome Measures:
  • Subjective pain score measurements after SMS

Estimated Enrollment: 30
Study Start Date: August 2006
Estimated Study Completion Date: December 2006
Detailed Description:

You must be aware of that this is a placebo-controlled trial. This means that you may either receive real SMS or sham SMS. The latter involves a harmless process of ineffective stimulation, designed for comparison with real SMS. Whether you receive either form of treatment will be assigned randomly, and there will be a 50% chance of being assigned to either.

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All with neuropathic lower limb pain

Exclusion Criteria:

  • Contraindications to magnetic stimulation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00443469

Locations
Singapore
Singapore General Hospital Recruiting
Singapore, Singapore, 169608
Contact: YL Lo, MD     6 3265003     lo.yew.long@sgh.com.sg    
Sponsors and Collaborators
Singapore General Hospital
Investigators
Principal Investigator: YL Lo, MD National Neuroscience Institute, Singapore General Hospital
  More Information

Study ID Numbers: #64/2006
Study First Received: March 4, 2007
Last Updated: March 4, 2007
ClinicalTrials.gov Identifier: NCT00443469  
Health Authority: Singapore: Health Sciences Authority

Keywords provided by Singapore General Hospital:
magnetic stimulation
neuropathic pain
spinal
lower limb
clinical trial

Study placed in the following topic categories:
Pain

ClinicalTrials.gov processed this record on January 16, 2009